Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.65 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.60 |
| ▸ | FYN | P06241 | 1/20 | 0.59 |
| ▸ | CA12 | O43570 | 1/20 | 0.57 |
| ▸ | CA1 | P00915 | 1/20 | 0.57 |
| ▸ | CA2 | P00918 | 1/20 | 0.57 |
| ▸ | CA9 | Q16790 | 1/20 | 0.57 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | ESR1 | P03372 | 3/20 | 0.55 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.54 |
| ▸ | MKNK1 | Q9BUB5 | 3/20 | 0.53 |
| ▸ | MKNK2 | Q9HBH9 | 3/20 | 0.53 |
| ▸ | ERN1 | O75460 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydroquinone SCHEMBL8674228 | 0.92 | PARP10 (0.74) | PARP10FYNCA12CA1CA2 | |
| SCHEMBL28823636 | 0.92 | PARP10 (0.74) | PARP10FYNCA12CA1CA2 | |
| SCHEMBL162830 | 0.92 | PARP10 (0.74) | PARP10FYNCA12CA1CA2 | |
| Methane SCHEMBL28048015 | 0.90 | PARP10 (0.71) | PARP10FYNCA12CA1CA2 | |
| Ammonia Solution, Strong SCHEMBL28805645 | 0.90 | PARP10 (0.71) | PARP10FYNCA12CA1CA2 | |
| SCHEMBL28831945 | 0.90 | PARP10 (0.71) | PARP10FYNCA12CA1CA2 | |
| Hydrochloric Acid SCHEMBL3139339 | 0.90 | PARP10 (0.71) | PARP10FYNCA12CA1CA2 | |
| SCHEMBL1002578 | 0.89 | CA2 (0.67) | PARP10CA12CA1CA2CA9 | |
| SCHEMBL25338154 | 0.85 | PARP10 (0.65) | PARP10FYNCA12CA1CA2 | |
| SCHEMBL4300988 | 0.83 | PARP10 (0.63) | PARP10FYNCA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-8208578-A | — | — | None | — | — | JP | disclosed |
| JP-8208586-A | — | — | None | — | — | JP | disclosed |
| US-20240287175-A1 | COMPOSITIONS AND METHODS FOR TREATING AGE-RELATED DISEASES | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2024-08-29 | — | — | US | disclosed |
| US-11891442-B2 | Compositions and methods for treating age-related diseases | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2024-02-06 | — | — | US | disclosed |
| US-20230174668-A1 | COMPOSITIONS AND METHODS FOR TREATING LYSOSOMAL STORAGE DISORDERS | THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS | 2023-06-08 | — | — | US | disclosed |
| US-20220315926-A1 | An Aptamer for Dengue Virus and Related Methods and Products | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2022-10-06 | — | — | US | disclosed |
| WO-2022149617-A1 | COMPOUND LIBRARY | 中外製薬株式会社 | 2022-07-14 | — | — | WO | disclosed |
| WO-2021236577-A1 | COMPOSITIONS AND METHODS FOR TREATING LYSOSOMAL STORAGE DISORDERS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2021-11-25 | — | — | WO | disclosed |
| US-20200317778-A1 | COMPOSITIONS AND METHODS FOR TREATING AGE-RELATED DISEASES | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2020-10-08 | — | — | US | disclosed |
| EP-2739608-B1 | INSULIN SECRETION PROMOTING AGENTS | VAL-CHUM LTD PARTNERSHIP (CA) | 2017-09-06 | — | — | EP | disclosed |
| US-20110124559-A1 | NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS | SMITHKLINE BEECHAM CORPORATION (US) | 2011-05-26 | — | — | US | disclosed |
| US-20100113512-A1 | METHOD OF TREATMENT USING NOVEL ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS | IGNAR DIANE MICHELE | 2010-05-06 | — | — | US | disclosed |
| US-20100113512-A1 | METHOD OF TREATMENT USING NOVEL ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS | IGNAR DIANE MICHELE | 2010-05-06 | — | — | US | disclosed |
| US-20100113512-A1 | METHOD OF TREATMENT USING NOVEL ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS | IGNAR DIANE MICHELE | 2010-05-06 | — | — | US | disclosed |
| WO-2010025235-A1 | SELECTIVE LIGANDS FOR THE DOPAMINE 3 (D3) RECEPTOR AND METHODS OF USING THE SAME | REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2010-03-04 | — | — | WO | disclosed |
| EP-2054383-A2 | NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS | SmithKline Beecham Corporation (US) | 2009-05-06 | — | — | EP | disclosed |
| WO-2008021849-A2 | NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS | SMITHKLINE BEECHAM CORPORATION (US) | 2008-02-21 | — | — | WO | disclosed |
| WO-2008021849-A2 | NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS | SMITHKLINE BEECHAM CORPORATION (US) | 2008-02-21 | — | — | WO | disclosed |
| JP-H08208578-A | 4'-CARBAMOYLBIPHENYL COMPOUND AND ITS PRODUCTION | SANKO CHEM CO LTD | 1996-08-13 | — | — | JP | disclosed |
| JP-H08208586-A | PRODUCTION OF 4'-CYANOBIPHENYL-4-OL | SANKO CHEM CO LTD | 1996-08-13 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110124559-A1 | NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS | OPRL1, OPRM1, OPRK1 | PARP10 3417/4885HSD17B1 2970/4885FYN 2651/4885 |
| US-20100113512-A1 | METHOD OF TREATMENT USING NOVEL ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS | OPRL1, OPRD1, OPRK1 | PARP10 4470/4885HSD17B1 1414/4885FYN 4593/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.